VQC-72059-71669
3 vaccinations
4 coded responses
26 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 287 / NC
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Energy increased, Increased appetite — Feeling: Good · Site: PainFree text: The day after second shot felt very high energy and increased appetite. I guess I would say amped up.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-21
- 2021-07-21
-
2021-11-15
Dose 3 — Pfizer-BioNTech
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body achesAdult check-in
-
2021-11-21
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: FairFree text: Persistent sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-22
Survey response — day 7, dose 3MedDRA: Cough, Oropharyngeal pain — Feeling: Fair · Fatigue or tirednessFree text: Sore throat and coughMedDRA releases: 2024-11 · check-in free text available
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
-
2022-02-14
Survey response — 3 months, dose 3MedDRA: Supraventricular tachycardia, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: SVT · Healthcare visit (other): Referral to cardiologyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-17
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-05-16
- 2022-11-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-14 | Successful 2022-02-17 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): The day after second shot felt very high energy and increased appetite. I guess I would say amped up.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Persistent sore throat
Release 10 — day 7, dose 3
Systemic reaction (other): Sore throat and cough
Release 11 — 3 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Supraventricular tachycardia | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Energy increased | ✓ | ✓ | ✓ |
| SRO | Increased appetite | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release